The metabotropic glutamate 5 receptor is necessary for extinction of cocaine-associated cues

British Journal of Pharmacology

Volumn 173, Issue 6, 2016, Pages 1085-1094

  Perry, Christina J ^a   Reed, Felicia ^b   Zbukvic, Isabel C ^a   Kim, Jee Hyun ^a   Lawrence, Andrew J ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 CYANO N (1,3 DIPHENYL 1H PYRAZOL 5 YL)BENZAMIDE; 3 [(2 METHYL 4 THIAZOLYL)ETHYNYL]PYRIDINE; BENZAMIDE; COCAINE; METABOTROPIC RECEPTOR 5; UNCLASSIFIED DRUG; 3-((2-METHYL-1,3-THIAZOL-4-YL)ETHYNYL)PYRIDINE; 3-CYANO-N-(1,3-DIPHENYL-1H-PYRAZOL-5-YL)BENZAMIDE; BENZAMIDE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; ALLOSTERISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR ASSESSMENT; BEHAVIOR THERAPY; COCAINE DEPENDENCE; CONTROLLED STUDY; CUE EXPOSURE THERAPY; DISEASE ASSOCIATION; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; REINFORCEMENT; RELAPSE; TREATMENT RESPONSE; ANIMAL; ASSOCIATION; CONDITIONING; DRUG EFFECTS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BENZAMIDES; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING (PSYCHOLOGY); CUES; MALE; PYRAZOLES; PYRIDINES; RATS, SPRAGUE-DAWLEY; RECEPTOR, METABOTROPIC GLUTAMATE 5; THIAZOLES;

EID: 84960121905     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13437     Document Type: Article

References (63)

1. Adams CL, Cowen MS, Short JL, Lawrence AJ, (2008). Combined antagonism of glutamate mGlu5 and adenosine A2A receptors interact to regulate alcohol-seeking in rats. Int J Neuropsychopharmacol 11: 229-241.
2. Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE, et al., (2015a). The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol 172: 5744-5869.
3. Alexander SPH, Peters JA, Kelly E, Marrion N, Benson HE, Faccenda E, et al., (2015b). The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels. Br J Pharmacol 172: 5870-5903.
4. Anderson JJ, Bradbury MJ, Giracello DR, Chapman DF, Holtz G, Roppe J, et al., (2003). In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine). Eur J Pharmacol 473: 35-40.
5. Backstrom P, Bachteler D, Koch S, Hyytia P, Spanagal R, (2004). mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology 29: 921-928.
6. Backstrom P, Hyytia P, (2006). Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking. Neuropsychopharmacology 31: 778-786.
7. Backstrom P, Hyytia P, (2007). Involvement of AMPA/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 192: 571-580.
8. Bespalov AY, Dravolina OA, Sukhanov I, Zakharova E, Blokhina E, Zvartau E, et al., (2005). Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats. Neuropharmacology 49 (Suppl 1): 167-178.
9. Bird KD., 2004. Analysis of Variance via Confidence Intervals. Sage Publications: London, ISBN: 0 7619 6357.
10. Bird MK, Lohmann P, West B, Brown RM, Kirchhoff J, Raymond CR, et al., (2014). The mGlu5 receptor regulates extinction of cocaine-driven behaviours. Drug Alcohol Depend 137: 83-89.
11. Bossert JM, Marchant NJ, Calu DJ, Shaham Y, (2013). The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology (Berl) 229: 453-476.
12. Bouton ME, (2002). Context, ambiguity, and unlearning: sources of relapse after behavioral extinction. Biol Psychiatry 52: 976-986.
13. Buffalari DM, Feltenstein MW, See RE, (2013). The effects of varied extinction procedures on contingent cue-induced reinstatement in Sprague-Dawley rats. Psychopharmacology (Berl) 230: 319-327.
14. Chesworth R, Brown RM, Kim JH, Lawrence AJ, (2013). The metabotropic glutamate 5 receptor modulates extinction and reinstatement of methamphetamine-seeking in mice. PLoS One 8, e68371.
15. Childress AR, McLellan AT, O'Brien CP, (1986). Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction. Br J Addict 81: 655-660.
16. Cleva RM, Hicks MP, Gass JT, Wischerath KC, Plasters ET, Widholm JJ, et al., (2011). mGluR5 positive allosteric modulation enhances extinction learning following cocaine self-administration. Behav Neurosci 125: 10-19.
17. Conklin CA, Tiffany ST, (2002). Applying extinction research and theory to cue-exposure addiction treatments. Addiction 97: 155-167.
18. Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SPA, Giembycz MA, et al., (2015). Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol 172: 3461-3471.
19. Farid WO, Lawrence AJ, Krstew EV, Tait RJ, Hulse GK, Dunlop SA, (2012). Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood. PLoS One 7, e52812.
20. Friedmann CTH, Davis LJ, Ciccone PE, Rubin RT, (1980). Phase-II double-blind controlled-study of a new anxiolytic, fenobam (Mcn-3377) vs placebo. Curr Ther Res Clin Exp 27: 144-151.
21. Ganella DE, Thangaraju P, Lawrence AJ, Kim JH, (2016). Fear extinction in 17 day old rats is dependent on metabotropic glutamate receptor 5 signaling. Behav Brain Res 298: 32-36 [PMID: 25497704].
22. Gao C, Tronson NC, Radulovic J, (2013). Modulation of behavior by scaffolding proteins of the post-synaptic density. Neurobiol Learn Mem 105: 3-12.
23. Gass JT, Olive MF, (2009). Positive allosteric modulation of mGluR5 receptors facilitates extinction of a cocaine contextual memory. Biol Psychiatry 65: 717-720.
24. Gass JT, Trantham-Davidson H, Kassab AS, Glen WB Jr, Olive MF, Chandler LJ, (2014). Enhancement of extinction learning attenuates ethanol-seeking behavior and alters plasticity in the prefrontal cortex. J Neurosci 34: 7562-7574.
25. Hao Y, Martin-Fardon R, Weiss F, (2010). Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence. Biol Psychiatry 68: 240-248.
26. Hutton-Bedbrook K, McNally GP, (2013). The promises and pitfalls of retrieval-extinction procedures in preventing relapse to drug seeking. Front Psychiatr 4: 14.
27. Inta D, Filipovic D, Lima-Ojeda JM, Dormann C, Pfeiffer N, Gaspaini F, et al., (2012). The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drug. Neuropsychopharmacology 62: 2034-2039.
28. Keck TM, Yang HJ, Bi GH, Huang Y, Zhang HY, Srivastava R, et al., (2013). Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans. Psychopharmacology (Berl) 229: 253-265.
29. Keck TM, Zou MF, Bi GH, Zhang HY, Wang XF, Yang HJ, et al., (2014). A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats. Addict Biol 19: 195-209.
30. Kenny PJ, Boutrel B, Gasparini F, Koob GF, Markou A, (2005). Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats. Psychopharmacology (Berl) 179: 247-254.
31. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
32. Kim JH, Lawrence AJ, (2014). Drugs currently in Phase II clinical trials for cocaine addiction. Expert Opin Investig Drugs 23: 1105-1122.
33. Kim JH, Perry C, Luikinga S, Zbukvic I, Brown RM, Lawrence AJ, (2015). Extinction of a cocaine-taking context that protects against drug-primed reinstatement is dependent on the metabotropic glutamate 5 receptor. Addict Biol 20: 482-489.
34. Kinney GG, O'Brien JA, LeMaire W, Burno M, Bickel DJ, Clements MK, et al., (2005). A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models. J Pharmacol Exp Ther 313: 199-206.
35. Kufahl PR, Hood LE, Nemirovsky NE, Barabas P, Halstengard C, Villa A, et al., (2012). Positive allosteric modulation of mGluR5 accelerates extinction learning but not relearning following methamphetamine self-administration. Front Pharmacol 3: 194.
36. Kumaresan V, Yuan M, Yee J, Famous KR, Anderson SM, Schmidt HD, et al., (2009). Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking. Behav Brain Res 202: 238-244.
37. LeBlanc KH, Ostlund SB, Maidment NT, (2012). Pavlovian-to-instrumental transfer in cocaine seeking rats. Behav Neurosci 126: 681-689.
38. Lu YM, Jia Z, Janus C, Henderson JT, Gerlai R, Wojtowicz JM, et al., (1997). Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci 17: 5196-5205.
39. Manahan-Vaughan D, Braunewell KH, (2005). The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. Cereb Cortex 15: 1703-1713.
40. Mantsch JR, Baker DA, Funk D, Le AD, Shaham Y, (2016). Stress-induced reinstatement of drug seeking: 20 years of progress. Neuropsychopharmacology 41: 335-356 [PMID: 25976297].
41. Martin-Fardon R, Baptista MA, Dayas CV, Weiss F, (2009). Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer. J Pharmacol Exp Ther 329: 1084-1090.
42. McGrath JC, Lilley E, (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172: 3189-3193.
43. Millan EZ, Milligan-Saville J, McNally GP, (2013). Memory retrieval, extinction, and reinstatement of alcohol seeking. Neurobiol Learn Mem 101: 26-32.
44. Monfils MH, Cowansage KK, Klann E, LeDoux JE, (2009). Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories. Science 324: 951-955.
45. Nader K, Schafe GE, LeDoux JE, (2000). The labile nature of consolidation theory. Nat Rev Neurosci 1: 216-219.
46. Nickols HH, Conn PJ, (2014). Development of allosteric modulators of GPCRs for treatment of CNS disorders. Neurobiol Dis 61: 55-71.
47. Niswender CM, Conn PJ, (2010). Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 50: 295-322.
48. Olive MF, (2010). Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction. Eur J Pharmacol 639: 47-58.
49. Paterson NE, Markou A, (2005). The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacology (Berl) 179: 255-261.
50. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al., (2014). The IUPHAR/BPS guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucleic Acids Res 42: D1098-D1106.
51. Pecknold JC, McClure DJ, Appeltauer L, Wrzesinski L, Allan T, (1982). Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study. J Clin Psychopharmacol 2: 129-133.
52. Perry CJ, Zbukvic I, Kim JH, Lawrence AJ, (2014). Role of cues and contexts on drug-seeking behaviour. Br J Pharmacol 171: 4636-4672.
53. Peters J, Kalivas PW, Quirk GJ, (2009). Extinction circuits for fear and addiction overlap in prefrontal cortex. Learn Mem 16: 279-288.
54. Romano C, Sesma MA, McDonald CT, O'Malley K, Van den Pol AN, Olney JW, (1995). Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 355: 455-469.
55. Shultz W, (1998). Predictive reward signal of dopamine neurons. J Neurophysiol 80: 1-27.
56. Tan SZ, Ganella DE, Dick AL, Duncan JR, Ong-Palsson E, Bathgate RA, et al., (2015). Spatial learning requires mGlu5 signalling in the dorsal hippocampus. Neurochem Res 40: 1303-1310.
57. Taylor JR, Olausson P, Quinn JJ, Torregrossa MM, (2009). Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction. Neuropharmacology 56 (Suppl 1): 186-195.
58. Torregrossa MM, Gordon J, Taylor JR, (2013). Double dissociation between the anterior cingulate cortex and nucleus accumbens core in encoding the context versus the content of Pavlovian cocaine cue extinction. J Neurosci 33: 8370-8377.
59. Torregrossa MM, Sanchez H, Taylor JR, (2010). d -cycloserine reduces the context specificity of Pavlovian extinction of cocaine cues through actions in the nucleus accumbens. J Neurosci 30: 10526-10533.
60. Torregrossa MM, Taylor JR, (2013). Learning to forget: manipulating extinction and reconsolidation processes to treat addiction. Psychopharmacology (Berl) 226: 659-672.
61. Vranjkovic O, Gasser PJ, Gerndt CH, Baker DA, Mantsch JR, (2014). Stress-induced cocaine seeking requires a beta-2 adrenergic receptor-regulated pathway from the ventral bed nucleus of the stria terminalis that regulates CRF actions in the ventral tegmental area. J Neurosci 34: 12504-12514.
62. Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Hood LE, Olive MF, (2013). Attenuation of reinstatement of methamphetamine-, sucrose-, and food-seeking behavior in rats by fenobam, a metabotropic glutamate receptor 5 negative allosteric modulator. Psychopharmacology (Berl) 225: 151-159.
63. Xue YX, Luo YX, Wu P, Shi HS, Xue LF, Chen C, et al., (2012). A memory retrieval-extinction procedure to prevent drug craving and relapse. Science 336: 241-245.